Oncolytics Biotech INC (ONCY) — SEC Filings

Q: What are the key financial highlights for Oncolytics Biotech INC?

Key financial highlights for Oncolytics Biotech INC are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: What is the investment thesis for ONCY?

The investment thesis for ONCY includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings filed by Oncolytics Biotech INC.

Q: Who are the key executives at Oncolytics Biotech INC?

Key executives at Oncolytics Biotech INC are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Oncolytics Biotech INC stock?

Risk factors for Oncolytics Biotech INC (ONCY) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Oncolytics Biotech INC?

Forward-looking statements and predictions from Oncolytics Biotech INC are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Oncolytics Biotech INC. Recent AW filing on Apr 8, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Oncolytics Biotech INC on SEC EDGAR

Overview

Oncolytics Biotech INC (ONCY) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a AW filed on Apr 8, 2026: Oncolytics Biotech Inc. filed an Amendment Withdrawal Request (Form AW) on April 8, 2026, under accession number 0001104659-26-040988. The filing was accepted on the same date. The company's mailing and business address is Suite 325, 4350 Executive Drive, San Diego, CA 92121.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant filing sentiment for Oncolytics Biotech INC is neutral.

Filing Type Overview

Oncolytics Biotech INC (ONCY) has filed 2 AW, 2 8-K, 2 EFFECT, 44 6-K with the SEC between Dec 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

AW Filing — AW · Apr 8, 2026
Oncolytics Biotech Files Amendment Withdrawal Request — AW · Apr 8, 2026 Risk: low
Oncolytics Biotech Inc. filed an Amendment Withdrawal Request (Form AW) on April 8, 2026, under accession number 0001104659-26-040988. The filing was accepted o
8-K Filing — 8-K · Apr 6, 2026
Oncolytics Biotech SEC Filing Effectiveness — EFFECT · Apr 6, 2026 Risk: low
Oncolytics Biotech Inc. filed an EFFECT form on April 6, 2026, indicating the effectiveness of a registration statement. The filing relates to Act 33 and has th
EFFECT Filing — EFFECT · Apr 2, 2026
8-K Filing — 8-K · Apr 1, 2026
6-K Filing — 6-K · Dec 16, 2025
Oncolytics Biotech Reschedules AGM for Audited Financials — 6-K · Dec 10, 2025 Risk: medium
Oncolytics Biotech Inc. has rescheduled its annual general meeting of shareholders to December 19, 2025. The meeting will now take place at 10:00 AM PST and wil
Oncolytics Biotech Inc. Files 6-K Update — 6-K · Nov 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 20, 2025, reporting as a foreign private issuer. The filing provides an update related to a special meeting
Oncolytics Biotech Files 6-K — 6-K · Nov 19, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 19, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive off
Oncolytics Biotech Files Routine 6-K Report — 6-K · Nov 12, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 12, 2025, reporting for the period ending September 30, 2025. The company, based in Calgary, Canada, is a f
Oncolytics Biotech Files 6-K — 6-K · Nov 4, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 4, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files 6-K — 6-K · Oct 28, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 28, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files 6-K — 6-K · Oct 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 20, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files October 6-K Report — 6-K · Oct 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 20, 2025, for the month of October 2025. The company is a foreign private issuer based in Calgary, Alberta,
Oncolytics Biotech Files October 2025 6-K Report — 6-K · Oct 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 10, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved
Oncolytics Biotech Files 6-K — 6-K · Sep 29, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 29, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a phar
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Sep 16, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 16, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a phar
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Sep 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 8, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Files Routine 6-K Report — 6-K · Sep 2, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 2, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the
Oncolytics Biotech Inc. Files Routine 6-K Report — 6-K · Aug 28, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 28, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is subject t
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Aug 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 11, 2025, reporting its status as a foreign private issuer. The company is based in Calgary, Alberta, Canada,
Oncolytics Biotech Inc. Files Routine 6-K Report — 6-K · Aug 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 8, 2025, reporting for the period ending June 30, 2025. The company, based in Calgary, Alberta, Canada, is a
Oncolytics Biotech Inc. Files 6-K with Incorporated Information Circular — 6-K · Aug 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 8, 2025, incorporating by reference an Information Circular from a previous filing on July 8, 2025. This circ
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Aug 5, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 5, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Pha
Oncolytics Biotech Files 6-K Report — 6-K · Jul 29, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 29, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved in
Oncolytics Biotech Files 6-K Report — 6-K · Jul 23, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 23, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Phar
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Jul 22, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 22, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceu
Oncolytics Biotech Files 6-K Report — 6-K · Jul 16, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 16, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceu
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Jul 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 10, 2025, reporting as a foreign private issuer for the month of July 2025. The company is based in Calgary, Al
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Jul 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 8, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Inc. Files June 2025 6-K Report — 6-K · Jun 30, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on June 30, 2025, reporting for the month of June 2025. The company, based in Calgary, Alberta, Canada, is a foreign pr
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Jun 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on June 11, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Inc. Files 6-K Report — 6-K · May 23, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 23, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Files May 2025 Financial Report — 6-K · May 14, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 14, 2025, reporting its financial results for the month of May 2025. The company is a foreign private issuer bas
Oncolytics Biotech Inc. Files May 2025 6-K Report — 6-K · May 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 8, 2025, reporting for the month of May 2025. The company is a foreign private issuer based in Calgary, Alberta,
Oncolytics Biotech Files 6-K — 6-K · Apr 24, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The filing indicates the company is based in Calgary, Alberta
Oncolytics Biotech Inc. Files April 2025 6-K Report — 6-K · Apr 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 11, 2025, reporting for the month of April 2025. The company is a foreign private issuer based in Calgary, Alb
Oncolytics Biotech Files 6-K Report — 6-K · Apr 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 10, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmace
Oncolytics Biotech Enters Purchase Agreement — 6-K · Apr 10, 2025 Risk: low
On April 10, 2025, Oncolytics Biotech Inc. entered into a purchase agreement with Alumni Capital LP. This filing incorporates the purchase agreement as Exhibit
Oncolytics Biotech Files 6-K Report — 6-K · Mar 7, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on March 7, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its report unde
Oncolytics Biotech Files 6-K — 6-K · Feb 25, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 25, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Inc. Files February 2025 6-K Report — 6-K · Feb 19, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 19, 2025, reporting for the month of February 2025. The company is a foreign private issuer based in Calgar
Oncolytics Biotech Files February 2025 6-K Report — 6-K · Feb 18, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 18, 2025, reporting for the month of February 2025. The company, based in Calgary, Alberta, Canada, is a fo
Oncolytics Biotech Inc. Files 6-K Report — 6-K · Feb 14, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 14, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and its
Oncolytics Biotech Files 6-K for February 2025 — 6-K · Feb 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 10, 2025, reporting for the month of February 2025. The company is a foreign private issuer based in Calgar
Oncolytics Biotech Files 6-K Report — 6-K · Jan 22, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on January 22, 2025, reporting as a foreign private issuer for the month of January 2025. The company is based in Calga
Oncolytics Biotech Inc. Files 6-K — 6-K · Jan 15, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on January 15, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and opera
Oncolytics Biotech Files 6-K Report — 6-K · Dec 23, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on December 23, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Files 6-K — 6-K · Dec 18, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on December 18, 2024, reporting as a foreign private issuer for the month of December 2024. The company is based in Cal

Risk Profile

Risk Assessment: Of ONCY's 45 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 44 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Top Tags

foreign-private-issuer (36) · sec-filing (29) · reporting (17) · regulatory-filing (9) · 6-K (5) · administrative (4) · registration-statement (2) · routine-report (2) · pharmaceutical (2) · reporting-status (2)

Key Numbers

Accession Number: 0001104659-26-040988 — Unique identifier for the filing
Filing Date: 2026-04-06 — Date the EFFECT filing was accepted by the SEC.
Effectiveness Date: 2026-04-03 — The date the registration statement became effective.
SEC File Number: 001-38512 — Identifies the company's filing history with the SEC

Related Companies

ONCO · ONC

Frequently Asked Questions

What are the latest SEC filings for Oncolytics Biotech INC (ONCY)?

Oncolytics Biotech INC has 50 recent SEC filings from Dec 2024 to Apr 2026, including 44 6-K, 2 AW, 2 8-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ONCY filings?

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant sentiment is neutral.

Where can I find Oncolytics Biotech INC SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Oncolytics Biotech INC (ONCY) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Oncolytics Biotech INC?

Financial highlights for Oncolytics Biotech INC are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for ONCY?

Investment thesis data for ONCY will be available once enriched filings are processed.

Who are the key executives at Oncolytics Biotech INC?

Executive information for Oncolytics Biotech INC is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Oncolytics Biotech INC stock?

Of ONCY's 45 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 44 low-risk.

What are recent predictions and forward guidance from Oncolytics Biotech INC?

Forward guidance and predictions for Oncolytics Biotech INC are extracted from SEC filings as they are enriched.